MGEN - Miragen Therapeutics EPS beats by $0.07 beats on revenue August, 07 2019 04:35 PM Miragen Therapeutics Inc. Miragen Therapeutics (NASDAQ:MGEN): Q2 GAAP EPS of -$0.29 beats by $0.07.More news on: Miragen Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...